HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tetsuji Miura Selected Research

Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)

6/2012Role of connexin-43 in protective PI3K-Akt-GSK-3β signaling in cardiomyocytes.
1/2010Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
9/2007Delta-opioid receptor activation before ischemia reduces gap junction permeability in ischemic myocardium by PKC-epsilon-mediated phosphorylation of connexin 43.
9/2006Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by delta-opioid receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tetsuji Miura Research Topics

Disease

36Infarction (Infarctions)
02/2022 - 01/2002
27Insulin Resistance
11/2021 - 07/2003
26Ischemia
01/2018 - 07/2002
20Hypertension (High Blood Pressure)
09/2021 - 09/2002
18Heart Failure
12/2021 - 07/2009
18Myocardial Infarction
01/2020 - 01/2002
13Obesity
09/2021 - 08/2005
12Cardiovascular Diseases (Cardiovascular Disease)
04/2022 - 07/2003
11Necrosis
02/2021 - 10/2003
11Type 2 Diabetes Mellitus (MODY)
01/2021 - 12/2009
9Reperfusion Injury
02/2021 - 10/2003
8Coronary Artery Disease (Coronary Atherosclerosis)
04/2022 - 07/2003
8Diabetes Mellitus
01/2022 - 07/2003
7Dyslipidemias (Dyslipidemia)
09/2021 - 07/2003
7Myocardial Ischemia (Ischemic Heart Diseases)
01/2021 - 10/2003
7Atherosclerosis
01/2021 - 09/2003
6Fibrosis (Cirrhosis)
01/2021 - 03/2010
5Body Weight (Weight, Body)
01/2022 - 01/2002
5Atrial Fibrillation
03/2021 - 01/2017
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
05/2022 - 03/2010
4Proteinuria
01/2022 - 01/2014
4Hyperuricemia
09/2021 - 09/2019
4Liver Diseases (Liver Disease)
09/2021 - 11/2018
4Cardiac Arrhythmias (Arrythmia)
01/2021 - 04/2017
4Left Ventricular Dysfunction
01/2021 - 02/2006
4Out-of-Hospital Cardiac Arrest
01/2020 - 11/2005
4Hypercholesterolemia
01/2016 - 10/2002
3Ventricular Tachycardia
05/2022 - 10/2018
3Chronic Renal Insufficiency
02/2022 - 01/2016
3Cardiomyopathies (Cardiomyopathy)
01/2022 - 02/2013
3Peripheral Arterial Disease
01/2021 - 11/2006
3Acute Kidney Injury (Acute Renal Failure)
01/2020 - 12/2017
3Hypertrophy
05/2014 - 01/2011
3Ventricular Remodeling
04/2006 - 01/2002

Drug/Important Bio-Agent (IBA)

18Glucose (Dextrose)FDA LinkGeneric
01/2021 - 07/2003
18Fatty Acid-Binding ProteinsIBA
01/2021 - 01/2011
13Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2002
12Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2011
11Insulin (Novolin)FDA Link
01/2021 - 07/2003
9Adenosine Triphosphate (ATP)IBA
04/2022 - 07/2002
9salicylhydroxamic acid (SHAM)IBA
01/2018 - 01/2002
8AdiponectinIBA
01/2021 - 09/2003
8Mitochondrial Permeability Transition PoreIBA
01/2018 - 11/2007
8ErythropoietinFDA Link
12/2012 - 04/2006
7Uric Acid (Urate)IBA
11/2021 - 01/2018
7AdipokinesIBA
01/2021 - 04/2009
7Glycogen Synthase Kinase 3 betaIBA
10/2010 - 08/2006
6Hemoglobins (Hemoglobin)IBA
02/2022 - 01/2007
6Triglycerides (Triacylglycerol)IBA
11/2020 - 08/2005
5HDL CholesterolIBA
11/2021 - 08/2005
5LipidsIBA
01/2021 - 01/2011
5CytokinesIBA
01/2021 - 09/2002
5CholesterolIBA
09/2019 - 10/2002
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2012 - 07/2003
5Angiotensin IIIBA
03/2012 - 01/2002
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022 - 01/2011
4CreatinineIBA
01/2022 - 08/2020
4Hormones (Hormone)IBA
01/2021 - 09/2003
4Pharmaceutical PreparationsIBA
01/2021 - 02/2009
4IsoflavonesIBA
09/2016 - 01/2014
4Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
06/2012 - 09/2006
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
05/2012 - 12/2009
4Protein Kinases (Protein Kinase)IBA
12/2010 - 02/2009
4Protein Kinase C-epsilonIBA
02/2009 - 07/2002
4Protein Kinase CIBA
02/2009 - 10/2002
4lucifer yellowIBA
02/2009 - 01/2004
3NitrogenIBA
01/2022 - 08/2020
3Urea (Carbamide)FDA LinkGeneric
01/2022 - 08/2020
3Alanine Transaminase (SGPT)IBA
12/2021 - 01/2018
3empagliflozinIBA
01/2020 - 01/2018
3Sodium-Glucose Transporter 2 InhibitorsIBA
07/2019 - 01/2018
3AntioxidantsIBA
01/2019 - 09/2011
3Dihydrotachysterol (AT 10)IBA
01/2018 - 05/2006
3GenisteinIBA
09/2016 - 04/2004
3daidzeinIBA
09/2016 - 01/2014
3glyciteinIBA
09/2016 - 01/2014
3ResveratrolIBA
02/2013 - 03/2010
3Sirtuin 1IBA
02/2013 - 03/2010
3Messenger RNA (mRNA)IBA
02/2013 - 12/2004
3Cardiotonic Agents (Cardiac Stimulants)IBA
06/2012 - 11/2008
3Glycogen Synthase (Synthase I)IBA
01/2011 - 02/2009
3Phosphotransferases (Kinase)IBA
12/2010 - 07/2009
3Diazoxide (Hyperstat)FDA Link
11/2010 - 07/2002
3ATP Translocases Mitochondrial ADPIBA
11/2010 - 07/2009
3delta Opioid Receptors (delta Opioid Receptor)IBA
01/2010 - 09/2006
3Valsartan (Vals)FDA Link
01/2010 - 01/2002
3Connexin 43 (Connexin43)IBA
02/2009 - 01/2004
3Nicorandil (SG 75)IBA
10/2003 - 10/2002
2LDL CholesterolIBA
04/2022 - 11/2012
2Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022 - 12/2017
2C-Reactive ProteinIBA
11/2021 - 06/2015
2Xanthine DehydrogenaseIBA
09/2021 - 09/2019
2Warfarin (Coumadin)FDA LinkGeneric
03/2021 - 01/2017

Therapy/Procedure

16Therapeutics
02/2022 - 10/2002
4Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
05/2022 - 09/2006
4Renal Dialysis (Hemodialysis)
12/2021 - 01/2011
4Catheter Ablation
10/2020 - 01/2017
4Ligation
01/2018 - 05/2003
2Cardiac Rehabilitation
12/2021 - 01/2018
2Kidney Transplantation
03/2021 - 01/2017